1W have attempted to addres the requirements necessary for alveolar macrophage accessory cell function. 1W have also e ined the in vtn and usWivo factors that must be taken into account when interpreting rsults from experimental studies. Differences in phenotypic expression by rat alveolar pleural and peritoneal macrophages are noted, as wel as the diffenng expression of major histocompatibility complex (MHC) class H molecules. Furthermore, alveolar macrophas harvested from rat lung, do not eqps thehrkin (IL-1cytokines, andlipopolyacharlde (LPS) treatmentofqulesentcels(after24-hrin vbculu) induceslw klew of p noflL-laand ELA16. Short-term inhalation of r ry c mic fibers, however, resFtInnarkedly increasedin IL-1,B inaftersImubtionwithLPS. IW sge that, in uvo, IL-1j3 may be involved in the idtial recruitment and activation of inflmmatory cels rather than in induction of immune responses. VW also stulate, based on recent published evidence, that alveolar macrophages activate the dendritic cels within the resplatory epithelium. Thus alveolar macrophages would release ytokines critcal for the activation of dendritic ceUs during the afferent limb of the imnune response, and they would respond to products of sensitized T-cels such as interferon-y and IL-4 to interact with T-helper ceUls in an antigen-spedfic MHC-restricted manner during the efferent limb ofthe response.
Introduction
In 1972, cells classified as mononuclear phagocyte were grouped together on the basis of having a common origin as demonstrated by kinetic studies and similar morphology, cytochemistry, and function (1) . The concept had the advantage of simplicity and would, it was thought, help clarify the role of mononuclear phagocytes in physiological and certain pathological conditions.
Fifteen years later, however, there is ample evidence that despite their probable origin from a common bone marrow progenitor population (2) , macrophages from different sites display considerable heterogeneity. This diversity is expressed by differences in phenotypic expression, secretory products, immunoregulation, and presentation of antigen. They also show differences in energy source. Some of these differences are discussed in the context ofthe secretory and accessory cell functions of the alveolar macrophage.
Phenotypic Subsets of Macrophages
Numerous reports exist of monoclonal antibodies that label macrophage/monocyte subpopulations in mouse and man, and in some instances these phenotypically defined subsets have been IImmunotoxicology Department, British Industrial Biological Research shown to mediate specific function. For example, the murine iC3b complement receptor Mac-I and the human equivalent recognized by anti-OKMI (3) appear on few tissue macrophages.
Mac-i is absent from Kupffer cells, and OKMI is expressed on only 25 % ofalveolar macrophages.
The rat is the favored animal in toxicological studies, but only recently have monoclonal antibodies delineating phenotypic subsets ofmacrophages in the rat been developed. Two groups, one in Oxford (4), the other in Amsterdam (5) , have clearly demonstrated differences between alveolar macrophages and macrophages from different sites, as well as heterogeneity among the alveolar macrophages. Our own findings are in agreement with the published reports (4, 5) in observing that alveolar macrophages are divided into subsets; additionally, we find differences in expression between alveolar, pleural, and peritoneal macrophages (Table 1) . Both MRC OX-41 and MRC OX-42 antibodies recognize cell-surface proteins that are synthesized by macrophages, although they also label granulocytes. MRC OX-42 recognizes an antigen associated with complement function (the iC3b-receptor). EDI and ED2 recognize mononuclear phagocytes exclusively; EDI recognizes a cytoplasmic antigen, whereas ED2 binds to membrane antigen. We found that cells recovered by bronchoalveolar lavage (BAL) from PVG rats were ED1 positive and ED2 negative; 90% were OX-41 positive and 20-30% were positive for OX-42. By contrast the majority of pleural macrophages bound all four antibodies, whereas resident peritoneal macrophages bound OX-41, OX-42, and EDI, but only 50% recognized the ED2 antibody (Table 2) . Thus, peritoneal macrophages differ from pleural cells in their phenotypic appear- 
Antigen Presentation/Regulation of Lymphocyte Proliferation
The accessory cell functions ofalveolar macrophages remains a subject of some considerable controversy in the published literature. One currently accepted postulate is that, at least in man, alveolar macrophages are capable of supporting antigendriven blastogenic responses by T-lymphocytes in in vitro studies, provided a low ratio of macrophages to T-lymphocytes are used. At higher ratios ofalveolar macrophages, suppressor factors would predominate, partially due to the release ofprostaglandins (PGE) by the macrophages (7). However, experimental work on murine macrophages provide suggestive evidence that the modulation ofalveolar macrophage-mediated suppression, unlike peritoneal and pleural macrophages, is independent of PGE production (8) (Fig. 2) Another cytokine, fibronectin, which is important in normal tissue turnover, wound repair, and inflanunatory processes, is not expressed inblood monocytesbut is expressed by mature mononuclear phagocytes, including alveolar and peritoneal macrophages (14) . However, in some circumstances such as when alveolarmacrophagesare activatedby surface stimuli, fibronectin mRNA is downregulated and the amount produced by the cells decreased. Clearly, the expression ofcytokines bymononuclear phagocytes isnotconstitutivebutmaybedependentonthe induction/activation signals and/or the physiological environment.
There may also be interspecies variation in the expression of cytokine genes just as there appears to be differences in the accessory activity ofalveolar macrophages from guinea pig, rabbit, or rat. In agreement with others, we find that alveolar macrophages, harvested from rat lung, do not express the IL-1 cytokine genes, and LPS treatment induces low levels of expression of ILI-ax or IL-,8. Short-term (5 day) inhalation exposure to refractory ceramic fibers did not in itself cause an increase in IL-1 or fibronectin gene expression. After these cells became quiescent, however, and then were stimulated with LPS for 3 hr IL-1 expression was markedly increased compared with controls (IS). It should perhaps be noted thatalthoughthese cells were "primed" by the fibers to respond to a second stimulus such as LPS, there was a lower level of inducibility ofthe membrane-bound IL-lax (associated with cell-cell contact and antigen presentation) than IL-1,8. This is in keeping with other studies which also show that IL-,8 is the form more readily synthesized and released by mononuclear phagocytes.
Because activated macrophages produce interleukin-1, and interleukin-I has been shown in in vitro assays to induce thymocyte and lymphocyte proliferation, it has been widely accepted that induction ofa proliferative response in lymphocytes also requires accessory cell release ofamplifying signals, such as those provided by interleukin-l. However, it should be remembered that IL-1 mediates a wide variety of biological responses to injury and infection including the production of the prostaglandin E series, pyrogenicity, and tissue destruction. IL-1 is also secreted in response to a wide range of antigen-independent stimuli. It is reasonable therefore to deduce that in wvo IL-1 is involved in the initial recruitment and activation ofcells at sites of inflammation rather than in induction ofimmune responses. Indeed, the most potent ofall accessory cells are the dendritic cells (which include the tissue dendritic cell, e.g., the Langerhans cells), and they do not produce interleukin-1 (16, 17) .
The dendritic cell lacks most conventional surface markers associated with the monocyte/macrophage lineage, and it is not clear whether the precursor is a discrete circulating cell or part of the conventional mononuclear phagocyte population (18 (27) has shown that rat peritoneal macrophages can be activated to produce GM-CSF and that macrophage-conditioned medium containing IL-1 and GM-CSF enhances the accessory activity of dendritic cells. Although the studies described above do not specifically relate to the lung, the important point is that GM-CSF and IL-1 are cytokines produced by non-T-cells such as macrophages and keratinocytes. Because alveolar macrophages are among the first cells to encounter antigens deposited in a nonlymphoid environment, they may be critically important in modulating the function of dendritic cells. The alveolar macrophage would either migrate across the alveolar epithelial barrier or cytokines produced by the macrophage could perfuse into the interstitium, thus activating the dendritic cell population. Most studies on cytokine production by activated alveolar macrophages have measured the production and release ofIL-1, TNF, and prostaglandins. There is an urgent need to study the capacity ofalveolar macrophages to express GM-CSF under different conditions of exposure. These of course can be released in the absence of sensitized T-cells.
Let us therefore test the hypothesis that the alveolar macrophage plays two important immunoregulatory roles. During the afferent limb of the immune response they release cytokines critical for the production of functionally active dendritic cells and may also pass on the processed antigen for attachment to the surface ofthe dendritic cell, whereas during the efferent limb of the local immune reaction they respond to products of sensitized T-cells such as INF and IL-4 to interact with T-helper cells in an antigen-specific, MHC-restricted manner or develop cytotoxic activity. The alveolar macrophage would thus control both induction and regulation ofcell-mediated immunity in the lung by virtue of two different mechanisms.
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